China Digest: IDG Capital backs Lyvgen's Series C; VirtAI Tech bags over $10m

China Digest: IDG Capital backs Lyvgen's Series C; VirtAI Tech bags over $10m

Source: Jan Antonin Kolar/Unsplash

Biopharmaceutical firm Lyvgen has raised “tens of millions of US dollars” in a Series C round led by IDG Capital, while AI accelerator Beijing VirtAI Technology has pocketed a similar amount in its Series A+ round led by China Mobile’s joint fund.

IDG leads biopharmaceutical firm Lyvgen’s Series C round

Lyvgen, a biopharmaceutical firm focussed on oncology immunotherapy, has announced the completion of “tens of millions of US dollars” in its Series C round of financing led by IDG Capital, according to a company statement on Tuesday.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter